4.6 Editorial Material

Targeting cancer stem cells with ALDH1A1-based immunotherapy

Journal

ONCOIMMUNOLOGY
Volume 1, Issue 3, Pages 384-386

Publisher

LANDES BIOSCIENCE
DOI: 10.4161/onci.18826

Keywords

ALDH1A1; CTL; adoptive therapy; cancer stem cells; xenograft

Ask authors/readers for more resources

ALDH(bright) cells in human tumor cells lines, xenografts and lesions have been shown to have characteristics of cancer stem cells (CSC). We have shown that these cells are recognized by ALDH1A1-specific CD8(+) T cells in vitro and in vivo. The results support the potential of ALDH1A1-based immunotherapy to target CSC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available